This inventor holds 1 USPTO granted patent. Top assignee: National Health Research Institutes. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Yi-Rong Chen: Innovator in Tyrosine Kinase Inhibitors
Introduction
Yi-Rong Chen is a notable inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target tyrosine kinases. His work is crucial in the ongoing fight against cancer.
Latest Patents
Yi-Rong Chen holds a patent for "Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors." This patent describes fused bicyclic or tricyclic compounds of a specific formula, wherein A, B, C, X, Y, m, and n are defined. The patent also discloses methods for inhibiting EGFR kinase activity and treating cancer using these innovative compounds. He has 1 patent to his name.
Career Highlights
Yi-Rong Chen is affiliated with the National Health Research Institutes, where he conducts research aimed at improving cancer treatment options. His work has the potential to lead to significant advancements in therapeutic strategies.
Collaborations
He collaborates with esteemed colleagues, including Hsing-Pang Hsieh and Selvaraj Mohane Coumar, to further enhance the impact of his research.
Conclusion
Yi-Rong Chen's innovative work in developing tyrosine kinase inhibitors represents a vital step forward in cancer treatment. His contributions to medicinal chemistry are noteworthy and continue to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile